Inventors:
William A. O'Brien - Galveston TX, US
Assignee:
The Board of Regents of the University of Texas System - Austin TX
International Classification:
A61K 39/395
US Classification:
4241301, 4241351, 4241391, 4241411, 4241421, 4241431, 4241441, 4241541
Abstract:
The invention provides a method of decreasing human immunodeficiency virus entry into cells, the method comprising decreasing levels of functional CD63 present with the human immunodeficiency virus and the cells. The invention further provides a method of treating or preventing human immunodeficiency virus infection in a subject, the method comprising administering to the subject an amount of a compound effective to decrease levels of functional CD63 in the cells of the subject.